What question did this study set out to answer?

April 27, 2026Open Access

Safety and tolerability of amustaline/glutathione pathogen‐reduced red blood cells in neonatal rats

ANAnne NorthCerus (United States)LCLaurence Corash RBRichard J. BenjaminCerus (United States)

Key Points

The study aims to evaluate the safety and tolerability of amustaline/glutathione pathogen-reduced red blood cells in neonatal rats.
Conducted a neonatal rat study to assess transfusion safety
Analyzed the tolerability of amustaline/GSH PR-RBCs
Amustaline/GSH PR-RBCs showed acceptable safety profiles in neonatal rats, indicating potential for pediatric use.

Abstract

The neonatal rat study demonstrates the safety and tolerability of amustaline/GSH PR-RBCs for transfusion and supports clinical use in pediatric patients.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

North et al. (Fri,) studied this question.

synapsesocial.com/papers/69eefd9bfede9185760d44b5 https://doi.org/https://doi.org/10.1111/trf.70240

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Demander à l'IA

Bookmark

View Full Paper